To the central content area
:::
:::Listed Companies > Listed Companies Info. > Main Board Companies > Listed Company Profile

General Stock Board Listed Company Profile

1784 BIONET CORP.
中文
Company Profile
Chairman CEO Spokesperson Tel Address Date of Listing (Regular)
Christopher Tsai Michael Kang Michael Kang (02)27951777 1F,No.28, Ln. 36 , Xinhu 1st Rd.Neihu Dist.,Taipei City 11497, , Taiwan 2007/07/26
Industry Main Business
Biotechnology and Medical Care BIONET is the first established and leading cord blood bank in Taiwan. The two major business are stem cell storage & therapy, and genetic testing. The services include: 1.Cord-Blood (CB) Storage: CB contains Hematopoietic Stem Cell (HSC), and it is the main source of human blood and immune system. It can cure the blood, immune system, and metabolism related diseases. 2.Mesenchymal Stem Cell (MSC) Storage: MSC can differentiate into tissues such as bones and nerves. It has many advantages such as the homing tendency and can adjust the immune reaction. 3.Stem Cell Revitalizer (SCR) Storage: From the mother’s placenta we have extracted the valuable SCR which contains ingredients of anti-aging effects. 4.Spinal Muscular Atrophy (SMA) Genetic Test: SMA is an autosomal recessive disorder with a carrier frequency of 1/25-1/30. If husband and wife are both carriers, 1/4 chance the baby is affected. Currently there is no cure, and can only prevent through pre-birth screening.
 
Market Information ( 2022/09/30 )
Shr. Vol. Highest Lowest Closed Change Transaction TurnOver(%) long
margin
balance
(1,000shr.)
Short
margin
balance
(1,000shr.)
206.893 39.40  37.30  39.40  -0.25  121 0.41 1,684 0
Trading method Fun
purchase
price or
securities
pneeded
on T day
Announcement of Irregularity
(2022/09/30)
TPEx measures
adopted
(2022/09/30)
With warrants Can be shorted or margined? Detail
Normal N N N N Y Today History
 
Financial Reports
Cash Flows Items
Amount
(NT$ thousand)
Cash flows from operating activities
Cash flows from investing activities
Cash flows from financing activities
Balance
Sheets
Current assets
Non-current assets
Total assets
Current liabilities
Non-current liabilities
Total liabilities
Share capital
Capital surplus
Retained earnings
Other equity interest
Treasury shares
Total equity attributable to owners of parent
Non-controlling interests
Total equity
Book Value per share(NT$)
Comprehensive Income Operating revenue
Operating costs
Gross profit from operations
Operating expenses
Net other income (expenses)
Net operating income
Non-operating income and expenses
Profit before tax
Tax expense
Profit from continuing operations
Profit from discontinued operations
Profit
Other comprehensive income
Comprehensive income
Basic earnings per share
 Auditor's report on latest financial statements: auditor's report:
 More detail:MOPS
 Foreign issuers’ information is disclosed in consolidated statements.